A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Myriad Genetics Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 1,063,711 shares of MYGN stock, worth $14.5 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
1,063,711
Previous 839,456 26.71%
Holding current value
$14.5 Million
Previous $20.5 Million 41.79%
% of portfolio
0.08%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.97 - $28.6 $5.38 Million - $6.41 Million
224,255 Added 26.71%
1,063,711 $29.1 Million
Q2 2024

Aug 14, 2024

BUY
$17.98 - $25.47 $1.1 Million - $1.56 Million
61,260 Added 7.87%
839,456 $20.5 Million
Q1 2024

May 15, 2024

BUY
$17.59 - $23.59 $13.7 Million - $18.4 Million
778,196 New
778,196 $16.6 Million
Q3 2023

Nov 14, 2023

BUY
$15.99 - $23.22 $41,589 - $60,395
2,601 Added 7431.43%
2,636 $42,000
Q2 2023

Aug 14, 2023

BUY
$17.56 - $23.76 $614 - $831
35 New
35 $0
Q1 2023

May 15, 2023

SELL
$15.26 - $23.75 $408,968 - $636,500
-26,800 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$14.51 - $20.99 $5.48 Million - $7.93 Million
-377,608 Reduced 93.37%
26,800 $388,000
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $3.19 Million - $4.88 Million
175,163 Added 76.41%
404,408 $7.72 Million
Q2 2022

Aug 15, 2022

BUY
$16.45 - $25.88 $1.34 Million - $2.11 Million
81,648 Added 55.32%
229,245 $4.17 Million
Q1 2022

May 16, 2022

BUY
$22.67 - $28.01 $3.35 Million - $4.13 Million
147,597 New
147,597 $3.72 Million
Q4 2021

Feb 14, 2022

SELL
$24.13 - $32.63 $5.78 Million - $7.81 Million
-239,493 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$29.97 - $36.66 $4.27 Million - $5.22 Million
-142,312 Reduced 37.27%
239,493 $7.73 Million
Q2 2021

Aug 16, 2021

SELL
$25.39 - $32.61 $407,331 - $523,162
-16,043 Reduced 4.03%
381,805 $11.7 Million
Q1 2021

May 17, 2021

BUY
$19.92 - $31.6 $572,500 - $908,184
28,740 Added 7.79%
397,848 $12.1 Million
Q4 2020

Feb 16, 2021

BUY
$12.16 - $19.77 $4.2 Million - $6.82 Million
345,029 Added 1432.9%
369,108 $7.3 Million
Q3 2020

Nov 16, 2020

BUY
$11.25 - $14.75 $270,888 - $355,165
24,079 New
24,079 $314,000
Q2 2020

Aug 14, 2020

SELL
$10.69 - $16.49 $1.51 Million - $2.33 Million
-141,500 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$9.78 - $29.53 $1.22 Million - $3.69 Million
124,839 Added 749.29%
141,500 $2.03 Million
Q4 2019

Feb 14, 2020

SELL
$20.93 - $35.1 $2.54 Million - $4.26 Million
-121,253 Reduced 87.92%
16,661 $454,000
Q3 2019

Nov 15, 2019

SELL
$22.08 - $47.08 $18.7 Million - $39.8 Million
-844,687 Reduced 85.96%
137,914 $3.95 Million
Q2 2019

Aug 14, 2019

BUY
$22.67 - $35.0 $8.15 Million - $12.6 Million
359,488 Added 57.69%
982,601 $27.3 Million
Q1 2019

May 15, 2019

SELL
$26.93 - $34.7 $8.44 Million - $10.9 Million
-313,394 Reduced 33.46%
623,113 $20.7 Million
Q4 2018

Feb 14, 2019

BUY
$27.23 - $45.56 $8.88 Million - $14.9 Million
326,187 Added 53.45%
936,507 $27.2 Million
Q3 2018

Nov 14, 2018

SELL
$37.57 - $50.34 $8.49 Million - $11.4 Million
-225,880 Reduced 27.01%
610,320 $28.1 Million
Q2 2018

Aug 14, 2018

SELL
$27.75 - $40.17 $1.3 Million - $1.87 Million
-46,674 Reduced 5.29%
836,200 $31.2 Million
Q1 2018

May 15, 2018

BUY
$28.83 - $41.01 $545,636 - $776,155
18,926 Added 2.19%
882,874 $26.1 Million
Q4 2017

Feb 14, 2018

BUY
$28.45 - $37.14 $24.6 Million - $32.1 Million
863,948
863,948 $29.7 Million

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.